David Sherris
Founder at Paloma Pharmaceuticals, Inc.
Profile
David Sherris was the founder of Paloma Pharmaceuticals, Inc. which was founded in 2005, where he held the titles of President, CEO, Treasurer & Director.
He held the position of Chief Scientific Officer at RestorGenex Corp.
from 2015 to 2016 and was the President of VasculoMedics, Inc. Dr. Sherris earned a doctorate degree from the University of Utah.
David Sherris active positions
| Companies | Position | Start |
|---|---|---|
Paloma Pharmaceuticals, Inc.
 Paloma Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Paloma Pharmaceuticals, Inc. manufactures pharmaceutical drugs and related products. The firm’s product Cialis which develops drugs for cancer, ocular diseases, arthritis, fibrotic diseases, antiviral, skin diseases and erectile dysfunction. The company is headquartered in Jamaica Plain, MA. | Founder | 2004-12-31 |
Former positions of David Sherris
| Companies | Position | End |
|---|---|---|
RestorGenex Corp.
 RestorGenex Corp. Pharmaceuticals: MajorHealth Technology RestorGenex Corp. operates as a specialty biopharmaceutical company, which focuses on developing products for dermatology, ophthalmology, and oncology. It products includes novel PI3K/Akt/mTOR pathway inhibitor which has completed two Phase I clinical trials for age-related macular degeneration and is in preclinical development in oncology, specifically glioblastoma multiforme. The company current pipeline also includes a soft anti-androgen compound for the treatment of acne vulgaris. RestorGenex was founded on March 14, 2008 and is headquartered in Buffalo Grove, IL. | Chief Tech/Sci/R&D Officer | 2016-01-07 |
VasculoMedics, Inc.
 VasculoMedics, Inc. BiotechnologyHealth Technology Part of CervoMed, Inc., VasculoMedics, Inc. is a company that produces and develops zinc finger transcription factors for medical use. The company is based in Jamaica Plain, MA. VasculoMedics was acquired by Stratus Media Group, Inc. on March 28, 2014 for $1.39 million. | President | - |
Training of David Sherris
| University of Utah | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 3 |
|---|---|
Paloma Pharmaceuticals, Inc.
Paloma Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Paloma Pharmaceuticals, Inc. manufactures pharmaceutical drugs and related products. The firm’s product Cialis which develops drugs for cancer, ocular diseases, arthritis, fibrotic diseases, antiviral, skin diseases and erectile dysfunction. The company is headquartered in Jamaica Plain, MA. | Health Technology |
RestorGenex Corp.
RestorGenex Corp. Pharmaceuticals: MajorHealth Technology RestorGenex Corp. operates as a specialty biopharmaceutical company, which focuses on developing products for dermatology, ophthalmology, and oncology. It products includes novel PI3K/Akt/mTOR pathway inhibitor which has completed two Phase I clinical trials for age-related macular degeneration and is in preclinical development in oncology, specifically glioblastoma multiforme. The company current pipeline also includes a soft anti-androgen compound for the treatment of acne vulgaris. RestorGenex was founded on March 14, 2008 and is headquartered in Buffalo Grove, IL. | Health Technology |
VasculoMedics, Inc.
VasculoMedics, Inc. BiotechnologyHealth Technology Part of CervoMed, Inc., VasculoMedics, Inc. is a company that produces and develops zinc finger transcription factors for medical use. The company is based in Jamaica Plain, MA. VasculoMedics was acquired by Stratus Media Group, Inc. on March 28, 2014 for $1.39 million. | Health Technology |
- Stock Market
- Insiders
- David Sherris
